Skip to main content
. Author manuscript; available in PMC: 2017 Jan 27.
Published in final edited form as: Eur J Med Chem. 2015 Dec 17;108:564–576. doi: 10.1016/j.ejmech.2015.12.028

Table 3.

Inhibition Data for Monoaryl Hydroxylamines with Ring Substitutiona

graphic file with name nihms746926u2.jpg
Compd X IC50(μM) Compd X IC50(μM) Compd X IC50(μM)
8 4-I 0.22± 0.066 16 3-F 1.0 24 2-OCH3 5.4
9 3-Cl 0.30± 0.015 17 4-Cl 1.3 25 4-CF3 8.9
10 3-Br 0.32± 0.042 18 2-F 1.4 26 3-OCH3 9.5
11 3-I 0.34± 0.12 19 4-Br 1.6 27 4-Ph 12
12 3-CF3 0.41 20 2-Br 1.6 28 4- CH(CH3)2 15
13 2-I 0.57 21 2-CF3 2.5 29 2-OH 19
14 2-Cl 0.63 22 3-CH3 2.7 30 4-OCH3 24
Lead H 0.81±0.081 23 4-NO2 2.7 31 4-OH 61
15 4-F 0.98
a

IC50 values are based on single point inhibition curves run once for each compound, but repeated at least 2x for the most potent compounds (initial IC50 values below 0.4 μM). These results are reported as the averages ± SD.

HHS Vulnerability Disclosure